nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—MMP9—systemic scleroderma	0.312	1	CbGaD
Glucosamine—osteoarthritis—Prednisone—systemic scleroderma	0.288	1	CpDpCtD
Glucosamine—MMP9—Captopril—systemic scleroderma	0.279	0.974	CbGbCtD
Glucosamine—CYP2C19—Prednisone—systemic scleroderma	0.00744	0.026	CbGbCtD
Glucosamine—MMP9—dermis—systemic scleroderma	0.00647	0.164	CbGeAlD
Glucosamine—MMP9—skeletal joint—systemic scleroderma	0.00559	0.141	CbGeAlD
Glucosamine—IFNG—endothelium—systemic scleroderma	0.00308	0.0778	CbGeAlD
Glucosamine—IFNG—blood vessel—systemic scleroderma	0.00284	0.0717	CbGeAlD
Glucosamine—MMP9—artery—systemic scleroderma	0.00234	0.0591	CbGeAlD
Glucosamine—MMP9—endothelium—systemic scleroderma	0.00198	0.0499	CbGeAlD
Glucosamine—MMP9—blood vessel—systemic scleroderma	0.00182	0.0461	CbGeAlD
Glucosamine—NFKB2—digestive system—systemic scleroderma	0.00155	0.0392	CbGeAlD
Glucosamine—NFKB2—tendon—systemic scleroderma	0.00147	0.0373	CbGeAlD
Glucosamine—IFNG—connective tissue—systemic scleroderma	0.00145	0.0368	CbGeAlD
Glucosamine—IFNG—skin of body—systemic scleroderma	0.00131	0.0332	CbGeAlD
Glucosamine—NFKB2—lung—systemic scleroderma	0.00129	0.0327	CbGeAlD
Glucosamine—IFNG—digestive system—systemic scleroderma	0.00105	0.0266	CbGeAlD
Glucosamine—IFNG—tendon—systemic scleroderma	0.001	0.0253	CbGeAlD
Glucosamine—MMP9—connective tissue—systemic scleroderma	0.000934	0.0236	CbGeAlD
Glucosamine—IFNG—lung—systemic scleroderma	0.000877	0.0222	CbGeAlD
Glucosamine—MMP9—smooth muscle tissue—systemic scleroderma	0.000854	0.0216	CbGeAlD
Glucosamine—MMP9—skin of body—systemic scleroderma	0.000843	0.0213	CbGeAlD
Glucosamine—MMP9—digestive system—systemic scleroderma	0.000674	0.0171	CbGeAlD
Glucosamine—MMP9—tendon—systemic scleroderma	0.000642	0.0162	CbGeAlD
Glucosamine—NFKB2—Betamethasone—Mometasone—systemic scleroderma	0.000563	0.324	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Mometasone—systemic scleroderma	0.000563	0.324	CbGdCrCtD
Glucosamine—MMP9—lung—systemic scleroderma	0.000563	0.0142	CbGeAlD
Glucosamine—NFKB2—Dexamethasone—Prednisone—systemic scleroderma	0.000307	0.176	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisone—systemic scleroderma	0.000307	0.176	CbGdCrCtD
Glucosamine—CYP2C19—digestive system—systemic scleroderma	0.000302	0.00765	CbGeAlD
Glucosamine—MMP9—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000298	0.00407	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—CSK—systemic scleroderma	0.000297	0.00405	CbGpPWpGaD
Glucosamine—MMP9—Degradation of the extracellular matrix—HSPG2—systemic scleroderma	0.000293	0.004	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—CTLA4—systemic scleroderma	0.000293	0.004	CbGpPWpGaD
Glucosamine—IFNG—IL1 and megakaryotyces in obesity—MMP9—systemic scleroderma	0.000292	0.00399	CbGpPWpGaD
Glucosamine—IFNG—IL27-mediated signaling events—IL1B—systemic scleroderma	0.000291	0.00397	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—STAT4—systemic scleroderma	0.00029	0.00396	CbGpPWpGaD
Glucosamine—IFNG—IL23-mediated signaling events—CCL2—systemic scleroderma	0.000289	0.00395	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000284	0.00388	CbGpPWpGaD
Glucosamine—IFNG—Cytokines and Inflammatory Response—IL1B—systemic scleroderma	0.000282	0.00385	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—CD247—systemic scleroderma	0.000279	0.00381	CbGpPWpGaD
Glucosamine—MMP9—Angiogenesis—NOS3—systemic scleroderma	0.000276	0.00377	CbGpPWpGaD
Glucosamine—NFKB2—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000276	0.00377	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—systemic scleroderma	0.000269	0.00368	CbGpPWpGaD
Glucosamine—IFNG—Interferon gamma signaling—HLA-DQB1—systemic scleroderma	0.000269	0.00367	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—SELP—systemic scleroderma	0.000266	0.00363	CbGpPWpGaD
Glucosamine—MMP9—Syndecan-1-mediated signaling events—MMP1—systemic scleroderma	0.000264	0.0036	CbGpPWpGaD
Glucosamine—MMP9—Collagen degradation—MMP1—systemic scleroderma	0.000264	0.0036	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.000261	0.00356	CbGpPWpGaD
Glucosamine—TNF—TNF receptor signaling pathway —TNFAIP3—systemic scleroderma	0.000259	0.00353	CbGpPWpGaD
Glucosamine—MMP9—CXCR4-mediated signaling events—BLK—systemic scleroderma	0.000258	0.00352	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—EDN1—systemic scleroderma	0.000254	0.00347	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IL1A—systemic scleroderma	0.000251	0.00343	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—CSF1—systemic scleroderma	0.00025	0.00341	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—RHOB—systemic scleroderma	0.000248	0.00339	CbGpPWpGaD
Glucosamine—MMP9—Matrix Metalloproteinases—MMP2—systemic scleroderma	0.000246	0.00337	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.000241	0.00329	CbGpPWpGaD
Glucosamine—MMP9—Osteopontin-mediated events—MMP2—systemic scleroderma	0.00024	0.00328	CbGpPWpGaD
Glucosamine—MMP9—IL1 and megakaryotyces in obesity—IL1B—systemic scleroderma	0.000235	0.00321	CbGpPWpGaD
Glucosamine—MMP9—amb2 Integrin signaling—MMP2—systemic scleroderma	0.000234	0.0032	CbGpPWpGaD
Glucosamine—MMP9—Activation of Matrix Metalloproteinases—MMP2—systemic scleroderma	0.000234	0.0032	CbGpPWpGaD
Glucosamine—NFKB2—TWEAK Signaling Pathway—MMP9—systemic scleroderma	0.00023	0.00315	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—IL1A—systemic scleroderma	0.000229	0.00313	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—CD40LG—systemic scleroderma	0.000228	0.00311	CbGpPWpGaD
Glucosamine—IFNG—IL27-mediated signaling events—TGFB1—systemic scleroderma	0.000226	0.00308	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—CCL2—systemic scleroderma	0.000225	0.00307	CbGpPWpGaD
Glucosamine—IFNG—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000224	0.00305	CbGpPWpGaD
Glucosamine—CYP2E1—digestive system—systemic scleroderma	0.000222	0.00562	CbGeAlD
Glucosamine—NFKB2—Signaling by Interleukins—IL1A—systemic scleroderma	0.00022	0.00301	CbGpPWpGaD
Glucosamine—IFNG—Interferon Signaling—IRF5—systemic scleroderma	0.00022	0.00301	CbGpPWpGaD
Glucosamine—IFNG—IL23-mediated signaling events—IL1B—systemic scleroderma	0.000219	0.00299	CbGpPWpGaD
Glucosamine—IFNG—Type II interferon signaling (IFNG)—IL1B—systemic scleroderma	0.000219	0.00299	CbGpPWpGaD
Glucosamine—IFNG—Cytokines and Inflammatory Response—TGFB1—systemic scleroderma	0.000219	0.00299	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic scleroderma	0.000219	0.00299	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—MMP1—systemic scleroderma	0.000213	0.00291	CbGpPWpGaD
Glucosamine—CYP2E1—tendon—systemic scleroderma	0.000211	0.00535	CbGeAlD
Glucosamine—IFNG—Interferon Signaling—IRF8—systemic scleroderma	0.00021	0.00287	CbGpPWpGaD
Glucosamine—NFKB2—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.000209	0.00286	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—systemic scleroderma	0.000208	0.00285	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—CD247—systemic scleroderma	0.000207	0.00283	CbGpPWpGaD
Glucosamine—MMP9—Collagen degradation—MMP2—systemic scleroderma	0.000204	0.00279	CbGpPWpGaD
Glucosamine—IFNG—IL12 signaling mediated by STAT4—TGFB1—systemic scleroderma	0.000201	0.00275	CbGpPWpGaD
Glucosamine—MMP9—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.000198	0.0027	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic scleroderma	0.000196	0.00268	CbGpPWpGaD
Glucosamine—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—systemic scleroderma	0.000195	0.00267	CbGpPWpGaD
Glucosamine—TNF—Matrix Metalloproteinases—MMP1—systemic scleroderma	0.000195	0.00266	CbGpPWpGaD
Glucosamine—IFNG—IFN-gamma pathway—IL1B—systemic scleroderma	0.000194	0.00265	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—EDN1—systemic scleroderma	0.000192	0.00263	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—MMP2—systemic scleroderma	0.000192	0.00262	CbGpPWpGaD
Glucosamine—IFNG—ATF-2 transcription factor network—MMP2—systemic scleroderma	0.000189	0.00259	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—MMP1—systemic scleroderma	0.000188	0.00257	CbGpPWpGaD
Glucosamine—CYP2E1—lung—systemic scleroderma	0.000186	0.00469	CbGeAlD
Glucosamine—IFNG—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	0.000184	0.00251	CbGpPWpGaD
Glucosamine—NFKB2—IL12-mediated signaling events—IL1B—systemic scleroderma	0.000184	0.00251	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000183	0.00249	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL1A—systemic scleroderma	0.000182	0.00249	CbGpPWpGaD
Glucosamine—TNF—Downstream signaling in naïve CD8+ T cells—STAT4—systemic scleroderma	0.000182	0.00249	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—CCL2—systemic scleroderma	0.000182	0.00248	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IRF5—systemic scleroderma	0.000181	0.00248	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—NOS3—systemic scleroderma	0.00018	0.00246	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—NOS3—systemic scleroderma	0.00018	0.00246	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—IRF5—systemic scleroderma	0.000179	0.00244	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000178	0.00244	CbGpPWpGaD
Glucosamine—TNF—FAS pathway and Stress induction of HSP regulation—IL1A—systemic scleroderma	0.000176	0.00241	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—FBN1—systemic scleroderma	0.000176	0.0024	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—CCL2—systemic scleroderma	0.000174	0.00237	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IRF8—systemic scleroderma	0.000173	0.00237	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	0.000172	0.00235	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—IL1B—systemic scleroderma	0.00017	0.00233	CbGpPWpGaD
Glucosamine—IFNG—Vitamin B12 Metabolism—IL1B—systemic scleroderma	0.00017	0.00232	CbGpPWpGaD
Glucosamine—MMP9—EPH-ephrin mediated repulsion of cells—MMP2—systemic scleroderma	0.000169	0.00231	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL13—systemic scleroderma	0.000169	0.00231	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL1A—systemic scleroderma	0.000166	0.00227	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000164	0.00224	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—SELP—systemic scleroderma	0.000163	0.00222	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—MMP1—systemic scleroderma	0.000162	0.00221	CbGpPWpGaD
Glucosamine—TNF—Cellular roles of Anthrax toxin—IL1B—systemic scleroderma	0.000154	0.00211	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IRF5—systemic scleroderma	0.000153	0.00209	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic scleroderma	0.000152	0.00208	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—RHOB—systemic scleroderma	0.000152	0.00207	CbGpPWpGaD
Glucosamine—TNF—Matrix Metalloproteinases—MMP2—systemic scleroderma	0.000151	0.00206	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	0.00015	0.00205	CbGpPWpGaD
Glucosamine—IFNG—IL12-mediated signaling events—IL1B—systemic scleroderma	0.000149	0.00203	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—TNFAIP3—systemic scleroderma	0.000149	0.00203	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IRF5—systemic scleroderma	0.000147	0.00201	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—CCL2—systemic scleroderma	0.000145	0.00197	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—MMP2—systemic scleroderma	0.000143	0.00196	CbGpPWpGaD
Glucosamine—IFNG—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	0.000143	0.00195	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IRF8—systemic scleroderma	0.00014	0.00192	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—IL1B—systemic scleroderma	0.000138	0.00188	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CTLA4—systemic scleroderma	0.000136	0.00186	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.000135	0.00185	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—IL1B—systemic scleroderma	0.000135	0.00184	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—MMP2—systemic scleroderma	0.000134	0.00184	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—CCL2—systemic scleroderma	0.000134	0.00183	CbGpPWpGaD
Glucosamine—MMP9—Degradation of the extracellular matrix—MMP1—systemic scleroderma	0.000133	0.00182	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—CCL2—systemic scleroderma	0.000132	0.0018	CbGpPWpGaD
Glucosamine—IFNG—Interferon Signaling—HLA-DQB1—systemic scleroderma	0.000131	0.00179	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000131	0.00179	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—IL1B—systemic scleroderma	0.000131	0.00179	CbGpPWpGaD
Glucosamine—MMP9—Syndecan-1-mediated signaling events—TGFB1—systemic scleroderma	0.000126	0.00173	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL1A—systemic scleroderma	0.000126	0.00172	CbGpPWpGaD
Glucosamine—IFNG—TGF-beta Receptor Signaling—TGFB1—systemic scleroderma	0.000126	0.00172	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—MMP9—systemic scleroderma	0.000124	0.00169	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—HSPG2—systemic scleroderma	0.000123	0.00168	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—NOS3—systemic scleroderma	0.000123	0.00168	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—COL1A2—systemic scleroderma	0.000123	0.00168	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—CCL2—systemic scleroderma	0.000121	0.00165	CbGpPWpGaD
Glucosamine—NFKB2—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	0.00012	0.00164	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—IL1B—systemic scleroderma	0.000119	0.00163	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IRF5—systemic scleroderma	0.000119	0.00163	CbGpPWpGaD
Glucosamine—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—systemic scleroderma	0.000117	0.00159	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—IL1B—systemic scleroderma	0.000115	0.00157	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—CCL2—systemic scleroderma	0.000114	0.00156	CbGpPWpGaD
Glucosamine—TNF—Monoamine Transport—IL1B—systemic scleroderma	0.000114	0.00156	CbGpPWpGaD
Glucosamine—TNF—Matrix Metalloproteinases—MMP9—systemic scleroderma	0.000113	0.00155	CbGpPWpGaD
Glucosamine—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—systemic scleroderma	0.000112	0.00154	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—HLA-DQB1—systemic scleroderma	0.000112	0.00153	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—ITGAM—systemic scleroderma	0.000112	0.00152	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—RHOB—systemic scleroderma	0.000111	0.00151	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—IL1B—systemic scleroderma	0.00011	0.0015	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	0.000108	0.00148	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—MMP9—systemic scleroderma	0.000108	0.00147	CbGpPWpGaD
Glucosamine—CYP2C19—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.000107	0.00146	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—TNFAIP3—systemic scleroderma	0.000107	0.00146	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL1A—systemic scleroderma	0.000106	0.00145	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CD40LG—systemic scleroderma	0.000106	0.00144	CbGpPWpGaD
Glucosamine—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic scleroderma	0.000105	0.00143	CbGpPWpGaD
Glucosamine—TNF—IL27-mediated signaling events—TGFB1—systemic scleroderma	0.000105	0.00143	CbGpPWpGaD
Glucosamine—IFNG—Regulation of Telomerase—TGFB1—systemic scleroderma	0.000105	0.00143	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—CCL2—systemic scleroderma	0.000104	0.00142	CbGpPWpGaD
Glucosamine—MMP9—Degradation of the extracellular matrix—MMP2—systemic scleroderma	0.000103	0.00141	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	0.000103	0.0014	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TGFB1—systemic scleroderma	0.000102	0.0014	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—EDN1—systemic scleroderma	0.000102	0.00139	CbGpPWpGaD
Glucosamine—TNF—IL23-mediated signaling events—IL1B—systemic scleroderma	0.000102	0.00139	CbGpPWpGaD
Glucosamine—TNF—Cytokines and Inflammatory Response—TGFB1—systemic scleroderma	0.000102	0.00139	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—MMP2—systemic scleroderma	0.0001	0.00137	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—MMP2—systemic scleroderma	9.88e-05	0.00135	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL13—systemic scleroderma	9.8e-05	0.00134	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ITGAM—systemic scleroderma	9.72e-05	0.00133	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CD247—systemic scleroderma	9.72e-05	0.00133	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IL1B—systemic scleroderma	9.52e-05	0.0013	CbGpPWpGaD
Glucosamine—TNF—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic scleroderma	9.39e-05	0.00128	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	9.38e-05	0.00128	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—TGFB1—systemic scleroderma	9.28e-05	0.00127	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TNFAIP3—systemic scleroderma	9.1e-05	0.00124	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TGFB1—systemic scleroderma	8.86e-05	0.00121	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HLA-DQB1—systemic scleroderma	8.77e-05	0.0012	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—IL1B—systemic scleroderma	8.67e-05	0.00118	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—MMP9—systemic scleroderma	8.66e-05	0.00118	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CCL2—systemic scleroderma	8.66e-05	0.00118	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	8.56e-05	0.00117	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	8.54e-05	0.00117	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—CCL2—systemic scleroderma	8.44e-05	0.00115	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—TGFB1—systemic scleroderma	8.33e-05	0.00114	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL1A—systemic scleroderma	8.33e-05	0.00114	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—MMP9—systemic scleroderma	8.17e-05	0.00112	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—RHOB—systemic scleroderma	7.89e-05	0.00108	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—IL1B—systemic scleroderma	7.87e-05	0.00107	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TGFB1—systemic scleroderma	7.75e-05	0.00106	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL1A—systemic scleroderma	7.71e-05	0.00105	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TGFB1—systemic scleroderma	7.39e-05	0.00101	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TGFB1—systemic scleroderma	6.74e-05	0.00092	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—CCL2—systemic scleroderma	6.71e-05	0.000916	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	6.64e-05	0.000907	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL1B—systemic scleroderma	6.57e-05	0.000897	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—CCL2—systemic scleroderma	6.47e-05	0.000884	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL1B—systemic scleroderma	6.4e-05	0.000874	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	6.17e-05	0.000842	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CSK—systemic scleroderma	6.02e-05	0.000822	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IRF5—systemic scleroderma	5.92e-05	0.000809	CbGpPWpGaD
Glucosamine—TNF—TGF-beta Receptor Signaling—TGFB1—systemic scleroderma	5.84e-05	0.000798	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—IL1A—systemic scleroderma	5.81e-05	0.000794	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—TGFB1—systemic scleroderma	5.76e-05	0.000786	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD247—systemic scleroderma	5.66e-05	0.000773	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IRF8—systemic scleroderma	5.66e-05	0.000773	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ITGAM—systemic scleroderma	5.66e-05	0.000773	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—MMP1—systemic scleroderma	5.59e-05	0.000764	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—IL1B—systemic scleroderma	5.54e-05	0.000757	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—IL1B—systemic scleroderma	5.54e-05	0.000757	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	5.36e-05	0.000732	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CCL2—systemic scleroderma	5.3e-05	0.000724	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TNFAIP3—systemic scleroderma	5.3e-05	0.000724	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—BLK—systemic scleroderma	5.24e-05	0.000715	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TGFB1—systemic scleroderma	5.1e-05	0.000697	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL1B—systemic scleroderma	5.09e-05	0.000695	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CSK—systemic scleroderma	4.88e-05	0.000666	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—RHOB—systemic scleroderma	4.83e-05	0.00066	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IRF5—systemic scleroderma	4.8e-05	0.000656	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IRF8—systemic scleroderma	4.59e-05	0.000626	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ITGAM—systemic scleroderma	4.59e-05	0.000626	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD247—systemic scleroderma	4.59e-05	0.000626	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL1B—systemic scleroderma	4.52e-05	0.000617	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic scleroderma	4.4e-05	0.000601	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL1B—systemic scleroderma	4.34e-05	0.000593	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—MMP2—systemic scleroderma	4.33e-05	0.000591	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—TGFB1—systemic scleroderma	4.31e-05	0.000588	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TNFAIP3—systemic scleroderma	4.3e-05	0.000587	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CTLA4—systemic scleroderma	4.29e-05	0.000586	CbGpPWpGaD
Glucosamine—IFNG—Immune System—BLK—systemic scleroderma	4.24e-05	0.00058	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—systemic scleroderma	4.1e-05	0.00056	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL1B—systemic scleroderma	4.02e-05	0.000549	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MMP9—systemic scleroderma	3.79e-05	0.000518	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MMP2—systemic scleroderma	3.67e-05	0.000502	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-DQB1—systemic scleroderma	3.53e-05	0.000483	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—systemic scleroderma	3.53e-05	0.000482	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CTLA4—systemic scleroderma	3.48e-05	0.000475	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SMAD7—systemic scleroderma	3.39e-05	0.000463	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1A—systemic scleroderma	3.36e-05	0.000458	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD40LG—systemic scleroderma	3.34e-05	0.000456	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	3.22e-05	0.000439	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TGFB1—systemic scleroderma	3.13e-05	0.000427	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—IL1B—systemic scleroderma	3.03e-05	0.000414	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—TGFB1—systemic scleroderma	2.89e-05	0.000395	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DQB1—systemic scleroderma	2.86e-05	0.000391	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1A—systemic scleroderma	2.72e-05	0.000371	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD40LG—systemic scleroderma	2.7e-05	0.000369	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—TGFB1—systemic scleroderma	2.68e-05	0.000366	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RHOB—systemic scleroderma	2.62e-05	0.000358	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MMP2—systemic scleroderma	2.62e-05	0.000358	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HSPG2—systemic scleroderma	2.48e-05	0.000338	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CSK—systemic scleroderma	2.39e-05	0.000326	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TGFB1—systemic scleroderma	2.36e-05	0.000322	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	2.13e-05	0.00029	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	1.83e-05	0.00025	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1B—systemic scleroderma	1.75e-05	0.000239	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TGFB1—systemic scleroderma	1.62e-05	0.000222	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP2—systemic scleroderma	1.6e-05	0.000219	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1B—systemic scleroderma	1.42e-05	0.000194	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.39e-05	0.000189	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EDN1—systemic scleroderma	1.34e-05	0.000183	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP9—systemic scleroderma	1.21e-05	0.000165	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—HSPG2—systemic scleroderma	1.06e-05	0.000144	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TGFB1—systemic scleroderma	9.94e-06	0.000136	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL2—systemic scleroderma	9.16e-06	0.000125	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NOS3—systemic scleroderma	8.17e-06	0.000112	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—HSPG2—systemic scleroderma	8.14e-06	0.000111	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CTGF—systemic scleroderma	8e-06	0.000109	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CTGF—systemic scleroderma	6.17e-06	8.43e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TGFB1—systemic scleroderma	5.4e-06	7.37e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NOS3—systemic scleroderma	3.48e-06	4.75e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NOS3—systemic scleroderma	2.69e-06	3.67e-05	CbGpPWpGaD
